Litcius/Paper detail

Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia

Luca Braga, Hashim Ali, Ilaria Secco, Elena Chiavacci, Guilherme Neves, Daniel H. Goldhill, Rebecca Penn, Jose M. Jiménez-Guardeño, Ana Maria Ortega‐Prieto, Rossana Bussani, Antonio Cannatà, Giorgia Rizzari, Chiara Collesi, Edoardo Schneider, Daniele Arosio, Ajay M. Shah, William Barclay, Michael H. Malim, Juan Burrone, Mauro Giacca

2021Nature440 citationsDOIOpen Access PDF

Topics & Concepts

SyncytiumPhospholipid scramblaseCell biologyCell fusionPhosphatidylserineBiologyPotentiatorCoronavirusCellNiclosamideChemistryPharmacologyBiochemistryMedicineCoronavirus disease 2019 (COVID-19)DiseaseMembranePhospholipidPathologyEcologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCalcium signaling and nucleotide metabolism
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia | Litcius